+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
STD Testing Market - Global Forecast 2026-2032- Product Image
STD Testing Market - Global Forecast 2026-2032- Product Image
Sale

STD Testing Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6083191
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The STD Testing Market is projected to reach USD 11.22 Billion in 2026. It is expected to continue growing at a CAGR of 6.12%, reaching USD 16.03 Billion by 2032.

STD Testing: Executive Summary and Strategic Context

STD testing encompasses laboratory and point-of-care services used to detect sexually transmitted infections, including bacterial, viral, and parasitic conditions. Demand is shaped by prevention priorities, screening guidelines, diagnostic access, confidentiality concerns, antimicrobial resistance, and the availability of accurate testing across clinical, community, and home-based settings. This summary focuses on verified structural developments and strategic implications without presenting market estimates or forecasts.

How Screening Delivery and Prevention Priorities Are Changing

The landscape is shifting from episodic, symptom-led testing toward more proactive screening, partner notification, vaccination, treatment, and prevention programs. Molecular methods have strengthened detection for infections that may be asymptomatic, while multiplex platforms can support more efficient clinical workflows. Public-health programs are also placing greater emphasis on reaching underserved populations through sexual-health clinics, primary care, pharmacies, community organizations, and outreach services. Persistent barriers include stigma, inconsistent access, differences in national guidelines, laboratory capacity constraints, and concerns about privacy and consent.

Artificial Intelligence Is Supporting Triage, Operations, and Interpretation

Artificial intelligence can contribute to STD-testing pathways by supporting risk assessment, appointment triage, demand routing, laboratory workflow management, quality control, and interpretation of complex diagnostic data. Its use requires representative training data, clinical validation, explainability, cybersecurity, and safeguards against discriminatory outcomes. AI should augment qualified clinicians and laboratory professionals rather than replace confirmatory testing, informed consent, clinical judgment, or public-health reporting. Strong governance is especially important when systems process sensitive sexual-health information.

Regional Insights: Uneven Access Meets Expanding Diagnostic Capability

North America combines advanced laboratory infrastructure with persistent disparities in screening access, affordability, and rural coverage. Latin America is characterized by varied public-health capacity, urban-rural gaps, and opportunities to expand integrated sexual-health services. Europe benefits from established surveillance and laboratory networks, although access and testing policies differ across countries. The Middle East continues to face privacy, stigma, and service-availability considerations that influence testing behavior. Africa requires sustained investment in decentralized diagnostics, workforce capacity, linkage to treatment, and prevention programs. Asia-Pacific presents substantial diversity, from highly developed testing systems to settings where affordability, geography, and awareness remain major constraints.

Group Insights: Policy Coordination and Access Priorities Differ

ASEAN members face varied regulatory environments, healthcare resources, and cross-border mobility patterns, making interoperable surveillance and accessible community testing valuable. BRICS countries span major differences in infrastructure and public-health delivery, creating a need for locally adapted screening and laboratory strategies. The European Union benefits from policy coordination and cross-border health cooperation, while national implementation remains uneven. G7 members generally have sophisticated diagnostic capabilities but continue to address inequities, stigma, and infection clusters. GCC countries are prioritizing accessible, confidential services within distinct regulatory and cultural contexts. NATO members must also consider continuity of essential diagnostics, supply resilience, and health-system preparedness during disruptions.

Country Insights: Diverse Testing Priorities Across Major Health Systems

Australia emphasizes prevention, surveillance, and access for geographically dispersed and priority populations. Brazil combines broad public-health capabilities with regional inequality and the need for consistent linkage to care. Canada must address rural and remote access, Indigenous health equity, and privacy-sensitive delivery. China is balancing large-scale screening capacity with regional variation and prevention needs. France, Germany, Italy, and Spain have established clinical and laboratory networks while continuing to address testing uptake, migrant access, and changing transmission patterns. India faces major diversity in healthcare access, workforce availability, and the need for decentralized services. Japan and South Korea have advanced health infrastructure alongside ongoing efforts to improve awareness and timely screening. Mexico is addressing geographic and socioeconomic disparities. Russia’s priorities include surveillance, treatment linkage, and service access across a large territory. The United Kingdom and United States are focusing on prevention, diagnostic accessibility, resistance monitoring, and equitable care across public and private settings.

Actions for Leaders: Build Trustworthy, Integrated Testing Pathways

Industry leaders should design services around confidentiality, informed consent, clear results communication, and rapid linkage to treatment. They should strengthen partnerships among laboratories, clinicians, public-health agencies, pharmacies, and community organizations; validate assays across relevant populations; and maintain robust quality-management and antimicrobial-resistance surveillance programs. Digital and AI-enabled tools should be introduced through measured pilots with documented clinical performance, human oversight, data minimization, and cybersecurity controls. Organizations should also map access gaps, support decentralized or self-collection models where clinically appropriate, and align programs with national guidelines and reporting requirements.

Research Methodology: Evidence-Led Review of Testing Systems and Drivers

This executive summary uses the defined STD-testing market scope and organizes findings across technology, care delivery, prevention, regulation, public-health infrastructure, and access. The analysis compares the required regions, country groups, and countries qualitatively, relying on established diagnostic and public-health principles rather than unsupported numerical claims. Interpretations prioritize verifiable structural trends, including molecular diagnostics, decentralized testing, privacy, surveillance, antimicrobial resistance, and AI governance. No market estimates, market shares, forecasts, or company-specific claims are included.

Conclusion: Accessible, Trusted Diagnostics Will Shape STD Testing

STD testing is evolving through stronger molecular diagnostics, broader prevention programs, decentralized delivery, digital engagement, and increasingly data-driven operations. The central strategic challenge is not only technical accuracy but also whether people can access testing confidentially, understand results, and receive timely treatment and prevention support. Leaders that combine validated diagnostics with equitable delivery, responsible data use, resilient partnerships, and locally appropriate public-health integration will be better positioned to improve testing uptake and health outcomes.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. STD Testing Market, by Test Type
7.1. Introduction
7.2. Culture Tests
7.2.1. Agar Based Culture
7.2.2. Cell Culture
7.3. Nucleic Acid Amplification Tests
7.3.1. Isothermal Amplification
7.3.2. PCR Based
7.4. Rapid Tests
7.4.1. Lateral Flow Assays
7.4.2. Point Of Care Platforms
7.5. Serology Tests
7.5.1. Enzyme Immunoassay
7.5.2. Lateral Flow Assays
8. STD Testing Market, by Product
8.1. Introduction
8.2. Instruments
8.3. Kits
8.4. Software & Services
9. STD Testing Market, by Technology
9.1. Introduction
9.2. Enzyme Immunoassay
9.3. Isothermal Amplification
9.4. Lateral Flow Assay
9.5. PCR Based
10. STD Testing Market, by Disease Type
10.1. Introduction
10.2. Chlamydia
10.3. Gonorrhea
10.4. Herpes
10.5. HIV
10.6. Syphilis
11. STD Testing Market, by Sample Type
11.1. Introduction
11.2. Blood
11.3. Saliva
11.4. Swab
11.5. Urine
12. STD Testing Market, by Distribution Channel
12.1. Introduction
12.2. Offline
12.3. Online
13. STD Testing Market, by End User
13.1. Introduction
13.2. Diagnostic Laboratories
13.3. Hospitals & Clinics
13.4. Point Of Care Testing Sites
13.5. Reference Laboratories
14. STD Testing Market, by Region
14.1. Introduction
14.2. Asia-Pacific
14.3. North America
14.4. Latin America
14.5. Europe
14.6. Middle East
14.7. Africa
15. STD Testing Market, by Group
15.1. Introduction
15.2. ASEAN
15.3. GCC
15.4. European Union
15.5. BRICS
15.6. G7
15.7. NATO
16. STD Testing Market, by Country
16.1. Introduction
16.2. United States
16.3. Canada
16.4. Mexico
16.5. Brazil
16.6. United Kingdom
16.7. Germany
16.8. France
16.9. Russia
16.10. Italy
16.11. Spain
16.12. China
16.13. India
16.14. Japan
16.15. Australia
16.16. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. Market Concentration Analysis, 2025
17.2.1. Concentration Ratio (CR)
17.2.2. Herfindahl Hirschman Index (HHI)
17.3. Recent Developments & Impact Analysis, 2025
17.4. Product Portfolio Analysis, 2025
17.5. Benchmarking Analysis, 2025
18. Company Profiles
18.1. Abbott Laboratories
18.2. Becton Dickinson and Company
18.3. Bio-Rad Laboratories, Inc.
18.4. Biocartis Group NV
18.5. bioMérieux SA
18.6. Danaher Corporation
18.7. DiaSorin S.p.A.
18.8. F. Hoffmann-La Roche AG
18.9. Grifols, S.A.
18.10. Hologic, Inc.
18.11. MedMira Inc.
18.12. Meridian Bioscience, Inc.
18.13. OraSure Technologies, Inc.
18.14. Quidel Corporation
18.15. Sekisui Diagnostics, LLC
18.16. Sysmex Corporation
18.17. Thermo Fisher Scientific Inc.
18.18. Trinity Biotech plc
19. Key Experts
LIST OF FIGURES
FIGURE 1. Global STD Testing Market, Years Considered for the Study
FIGURE 2. Global STD Testing Market, Research Design
FIGURE 3. Global STD Testing Market, Research Framework
FIGURE 4. Global STD Testing Market, Data Triangulation
FIGURE 5. Global STD Testing Market Size, 2017-2032 (USD Million)
FIGURE 6. Global STD Testing Market Size, by Test Type, 2025 vs 2032 (%)
FIGURE 7. Global STD Testing Market Size, by Test Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global STD Testing Market Size, by Product, 2025 vs 2032 (%)
FIGURE 9. Global STD Testing Market Size, by Product, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global STD Testing Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 11. Global STD Testing Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global STD Testing Market Size, by Disease Type, 2025 vs 2032 (%)
FIGURE 13. Global STD Testing Market Size, by Disease Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global STD Testing Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 15. Global STD Testing Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global STD Testing Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 17. Global STD Testing Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global STD Testing Market Size, by End User, 2025 vs 2032 (%)
FIGURE 19. Global STD Testing Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global STD Testing Market Size, by Region, 2025 vs 2032 (%)
FIGURE 21. Global STD Testing Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global STD Testing Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global STD Testing Market Size, by Country, 2025 vs 2032 (%)
FIGURE 24. Global STD Testing Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global STD Testing Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global STD Testing Market Segmentation & Coverage
TABLE 2. Global STD Testing Market Size, 2017-2032 (USD Million)
TABLE 3. Global STD Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 4. Global Culture Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Culture Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Culture Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Agar Based Culture Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Agar Based Culture Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Agar Based Culture Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Cell Culture Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Cell Culture Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Cell Culture Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Nucleic Acid Amplification Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Nucleic Acid Amplification Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Nucleic Acid Amplification Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Isothermal Amplification Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Isothermal Amplification Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Isothermal Amplification Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global PCR Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global PCR Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global PCR Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Rapid Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Rapid Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Rapid Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Lateral Flow Assays Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Lateral Flow Assays Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Lateral Flow Assays Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Point Of Care Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Point Of Care Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Point Of Care Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Serology Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Serology Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Serology Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Enzyme Immunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Enzyme Immunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Enzyme Immunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Lateral Flow Assays Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Lateral Flow Assays Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Lateral Flow Assays Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global STD Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 41. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Software & Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Software & Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Software & Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global STD Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 51. Global Enzyme Immunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Enzyme Immunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Enzyme Immunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Isothermal Amplification Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Isothermal Amplification Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Isothermal Amplification Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Lateral Flow Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Lateral Flow Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Lateral Flow Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global PCR Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global PCR Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global PCR Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global STD Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 64. Global Chlamydia Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Chlamydia Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Chlamydia Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Gonorrhea Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Gonorrhea Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Gonorrhea Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Herpes Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Herpes Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Herpes Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global HIV Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global HIV Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global HIV Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Syphilis Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Syphilis Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Syphilis Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global STD Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 80. Global Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Saliva Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Saliva Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Saliva Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Swab Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Swab Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Swab Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Urine Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Urine Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Urine Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global STD Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 93. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global STD Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 100. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Point Of Care Testing Sites Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Point Of Care Testing Sites Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Point Of Care Testing Sites Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Reference Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Reference Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Reference Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global STD Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific STD Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific STD Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 115. Asia-Pacific STD Testing Market Size, by Culture Tests, 2017-2032 (USD Million)
TABLE 116. Asia-Pacific STD Testing Market Size, by Nucleic Acid Amplification Tests, 2017-2032 (USD Million)
TABLE 117. Asia-Pacific STD Testing Market Size, by Rapid Tests, 2017-2032 (USD Million)
TABLE 118. Asia-Pacific STD Testing Market Size, by Serology Tests, 2017-2032 (USD Million)
TABLE 119. Asia-Pacific STD Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 120. Asia-Pacific STD Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 121. Asia-Pacific STD Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 122. Asia-Pacific STD Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific STD Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific STD Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 125. North America STD Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. North America STD Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 127. North America STD Testing Market Size, by Culture Tests, 2017-2032 (USD Million)
TABLE 128. North America STD Testing Market Size, by Nucleic Acid Amplification Tests, 2017-2032 (USD Million)
TABLE 129. North America STD Testing Market Size, by Rapid Tests, 2017-2032 (USD Million)
TABLE 130. North America STD Testing Market Size, by Serology Tests, 2017-2032 (USD Million)
TABLE 131. North America STD Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 132. North America STD Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 133. North America STD Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 134. North America STD Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 135. North America STD Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 136. North America STD Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 137. Latin America STD Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. Latin America STD Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 139. Latin America STD Testing Market Size, by Culture Tests, 2017-2032 (USD Million)
TABLE 140. Latin America STD Testing Market Size, by Nucleic Acid Amplification Tests, 2017-2032 (USD Million)
TABLE 141. Latin America STD Testing Market Size, by Rapid Tests, 2017-2032 (USD Million)
TABLE 142. Latin America STD Testing Market Size, by Serology Tests, 2017-2032 (USD Million)
TABLE 143. Latin America STD Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 144. Latin America STD Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 145. Latin America STD Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 146. Latin America STD Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 147. Latin America STD Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 148. Latin America STD Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. Europe STD Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Europe STD Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 151. Europe STD Testing Market Size, by Culture Tests, 2017-2032 (USD Million)
TABLE 152. Europe STD Testing Market Size, by Nucleic Acid Amplification Tests, 2017-2032 (USD Million)
TABLE 153. Europe STD Testing Market Size, by Rapid Tests, 2017-2032 (USD Million)
TABLE 154. Europe STD Testing Market Size, by Serology Tests, 2017-2032 (USD Million)
TABLE 155. Europe STD Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 156. Europe STD Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 157. Europe STD Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 158. Europe STD Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 159. Europe STD Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 160. Europe STD Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. Middle East STD Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 162. Middle East STD Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 163. Middle East STD Testing Market Size, by Culture Tests, 2017-2032 (USD Million)
TABLE 164. Middle East STD Testing Market Size, by Nucleic Acid Amplification Tests, 2017-2032 (USD Million)
TABLE 165. Middle East STD Testing Market Size, by Rapid Tests, 2017-2032 (USD Million)
TABLE 166. Middle East STD Testing Market Size, by Serology Tests, 2017-2032 (USD Million)
TABLE 167. Middle East STD Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 168. Middle East STD Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 169. Middle East STD Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 170. Middle East STD Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 171. Middle East STD Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 172. Middle East STD Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 173. Africa STD Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 174. Africa STD Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 175. Africa STD Testing Market Size, by Culture Tests, 2017-2032 (USD Million)
TABLE 176. Africa STD Testing Market Size, by Nucleic Acid Amplification Tests, 2017-2032 (USD Million)
TABLE 177. Africa STD Testing Market Size, by Rapid Tests, 2017-2032 (USD Million)
TABLE 178. Africa STD Testing Market Size, by Serology Tests, 2017-2032 (USD Million)
TABLE 179. Africa STD Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 180. Africa STD Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 181. Africa STD Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 182. Africa STD Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 183. Africa STD Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 184. Africa STD Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 185. Global STD Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 186. ASEAN STD Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 187. ASEAN STD Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 188. ASEAN STD Testing Market Size, by Culture Tests, 2017-2032 (USD Million)
TABLE 189. ASEAN STD Testing Market Size, by Nucleic Acid Amplification Tests, 2017-2032 (USD Million)
TABLE 190. ASEAN STD Testing Market Size, by Rapid Tests, 2017-2032 (USD Million)
TABLE 191. ASEAN STD Testing Market Size, by Serology Tests, 2017-2032 (USD Million)
TABLE 192. ASEAN STD Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 193. ASEAN STD Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 194. ASEAN STD Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 195. ASEAN STD Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 196. ASEAN STD Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 197. ASEAN STD Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 198. GCC STD Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 199. GCC STD Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 200. GCC STD Testing Market Size, by Culture Tests, 2017-2032 (USD Million)
TABLE 201. GCC STD Testing Market Size, by Nucleic Acid Amplification Tests, 2017-2032 (USD Million)
TABLE 202. GCC STD Testing Market Size, by Rapid Tests, 2017-2032 (USD Million)
TABLE 203. GCC STD Testing Market Size, by Serology Tests, 2017-2032 (USD Million)
TABLE 204. GCC STD Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 205. GCC STD Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 206. GCC STD Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 207. GCC STD Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 208. GCC STD Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 209. GCC STD Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 210. European Union STD Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 211. European Union STD Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 212. European Union STD Testing Market Size, by Culture Tests, 2017-2032 (USD Million)
TABLE 213. European Union STD Testing Market Size, by Nucleic Acid Amplification Tests, 2017-2032 (USD Million)
TABLE 214. European Union STD Testing Market Size, by Rapid Tests, 2017-2032 (USD Million)
TABLE 215. European Union STD Testing Market Size, by Serology Tests, 2017-2032 (USD Million)
TABLE 216. European Union STD Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 217. European Union STD Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 218. European Union STD Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 219. European Union STD Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 220. European Union STD Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 221. European Union STD Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 222. BRICS STD Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 223. BRICS STD Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 224. BRICS STD Testing Market Size, by Culture Tests, 2017-2032 (USD Million)
TABLE 225. BRICS STD Testing Market Size, by Nucleic Acid Amplification Tests, 2017-2032 (USD Million)
TABLE 226. BRICS STD Testing Market Size, by Rapid Tests, 2017-2032 (USD Million)
TABLE 227. BRICS STD Testing Market Size, by Serology Tests, 2017-2032 (USD Million)
TABLE 228. BRICS STD Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 229. BRICS STD Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 230. BRICS STD Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 231. BRICS STD Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 232. BRICS STD Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 233. BRICS STD Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 234. G7 STD Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 235. G7 STD Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 236. G7 STD Testing Market Size, by Culture Tests, 2017-2032 (USD Million)
TABLE 237. G7 STD Testing Market Size, by Nucleic Acid Amplification Tests, 2017-2032 (USD Million)
TABLE 238. G7 STD Testing Market Size, by Rapid Tests, 2017-2032 (USD Million)
TABLE 239. G7 STD Testing Market Size, by Serology Tests, 2017-2032 (USD Million)
TABLE 240. G7 STD Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 241. G7 STD Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 242. G7 STD Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 243. G7 STD Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 244. G7 STD Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 245. G7 STD Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 246. NATO STD Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 247. NATO STD Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 248. NATO STD Testing Market Size, by Culture Tests, 2017-2032 (USD Million)
TABLE 249. NATO STD Testing Market Size, by Nucleic Acid Amplification Tests, 2017-2032 (USD Million)
TABLE 250. NATO STD Testing Market Size, by Rapid Tests, 2017-2032 (USD Million)
TABLE 251. NATO STD Testing Market Size, by Serology Tests, 2017-2032 (USD Million)
TABLE 252. NATO STD Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 253. NATO STD Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 254. NATO STD Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 255. NATO STD Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 256. NATO STD Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 257. NATO STD Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 258. Global STD Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 259. United States STD Testing Market Size, 2017-2032 (USD Million)
TABLE 260. United States STD Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 261. United States STD Testing Market Size, by Culture Tests, 2017-2032 (USD Million)
TABLE 262. United States STD Testing Market Size, by Nucleic Acid Amplification Tests, 2017-2032 (USD Million)
TABLE 263. United States STD Testing Market Size, by Rapid Tests, 2017-2032 (USD Million)
TABLE 264. United States STD Testing Market Size, by Serology Tests, 2017-2032 (USD Million)
TABLE 265. United States STD Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 266. United States STD Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 267. United States STD Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 268. United States STD Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 269. United States STD Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 270. United States STD Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 271. Canada STD Testing Market Size, 2017-2032 (USD Million)
TABLE 272. Canada STD Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 273. Canada STD Testing Market Size, by Culture Tests, 2017-2032 (USD Million)
TABLE 274. Canada STD Testing Market Size, by Nucleic Acid Amplification Tests, 2017-2032 (USD Million)
TABLE 275. Canada STD Testing Market Size, by Rapid Tests, 2017-2032 (USD Million)
TABLE 276. Canada STD Testing Market Size, by Serology Tests, 2017-2032 (USD Million)
TABLE 277. Canada STD Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 278. Canada STD Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 279. Canada STD Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 280. Canada STD Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 281. Canada STD Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 282. Canada STD Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 283. Mexico STD Testing Market Size, 2017-2032 (USD Million)
TABLE 284. Mexico STD Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 285. Mexico STD Testing Market Size, by Culture Tests, 2017-2032 (USD Million)
TABLE 286. Mexico STD Testing Market Size, by Nucleic Acid Amplification Tests, 2017-2032 (USD Million)
TABLE 287. Mexico STD Testing Market Size, by Rapid Tests, 2017-2032 (USD Million)
TABLE 288. Mexico STD Testing Market Size, by Serology Tests, 2017-2032 (USD Million)
TABLE 289. Mexico STD Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 290. Mexico STD Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 291. Mexico STD Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 292. Mexico STD Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 293. Mexico STD Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 294. Mexico STD Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 295. Brazil STD Testing Market Size, 2017-2032 (USD Million)
TABLE 296. Brazil STD Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 297. Brazil STD Testing Market Size, by Culture Tests, 2017-2032 (USD Million)
TABLE 298. Brazil STD Testing Market Size, by Nucleic Acid Amplification Tests, 2017-2032 (USD Million)
TABLE 299. Brazil STD Testing Market Size, by Rapid Tests, 2017-2032 (USD Million)
TABLE 300. Brazil STD Testing Market Size, by Serology Tests, 2017-2032 (USD Million)
TABLE 301. Brazil STD Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 302. Brazil STD Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 303. Brazil STD Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 304. Brazil STD Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 305. Brazil STD Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 306. Brazil STD Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 307. United Kingdom STD Testing Market Size, 2017-2032 (USD Million)
TABLE 308. United Kingdom STD Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 309. United Kingdom STD Testing Market Size, by Culture Tests, 2017-2032 (USD Million)
TABLE 310. United Kingdom STD Testing Market Size, by Nucleic Acid Amplification Tests, 2017-2032 (USD Million)
TABLE 311. United Kingdom STD Testing Market Size, by Rapid Tests, 2017-2032 (USD Million)
TABLE 312. United Kingdom STD Testing Market Size, by Serology Tests, 2017-2032 (USD Million)
TABLE 313. United Kingdom STD Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 314. United Kingdom STD Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 315. United Kingdom STD Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 316. United Kingdom STD Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 317. United Kingdom STD Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 318. United Kingdom STD Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 319. Germany STD Testing Market Size, 2017-2032 (USD Million)
TABLE 320. Germany STD Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 321. Germany STD Testing Market Size, by Culture Tests, 2017-2032 (USD Million)
TABLE 322. Germany STD Testing Market Size, by Nucleic Acid Amplification Tests, 2017-2032 (USD Million)
TABLE 323. Germany STD Testing Market Size, by Rapid Tests, 2017-2032 (USD Million)
TABLE 324. Germany STD Testing Market Size, by Serology Tests, 2017-2032 (USD Million)
TABLE 325. Germany STD Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 326. Germany STD Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 327. Germany STD Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 328. Germany STD Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 329. Germany STD Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 330. Germany STD Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 331. France STD Testing Market Size, 2017-2032 (USD Million)
TABLE 332. France STD Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 333. France STD Testing Market Size, by Culture Tests, 2017-2032 (USD Million)
TABLE 334. France STD Testing Market Size, by Nucleic Acid Amplification Tests, 2017-2032 (USD Million)
TABLE 335. France STD Testing Market Size, by Rapid Tests, 2017-2032 (USD Million)
TABLE 336. France STD Testing Market Size, by Serology Tests, 2017-2032 (USD Million)
TABLE 337. France STD Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 338. France STD Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 339. France STD Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 340. France STD Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 341. France STD Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 342. France STD Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 343. Russia STD Testing Market Size, 2017-2032 (USD Million)
TABLE 344. Russia STD Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 345. Russia STD Testing Market Size, by Culture Tests, 2017-2032 (USD Million)
TABLE 346. Russia STD Testing Market Size, by Nucleic Acid Amplification Tests, 2017-2032 (USD Million)
TABLE 347. Russia STD Testing Market Size, by Rapid Tests, 2017-2032 (USD Million)
TABLE 348. Russia STD Testing Market Size, by Serology Tests, 2017-2032 (USD Million)
TABLE 349. Russia STD Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 350. Russia STD Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 351. Russia STD Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 352. Russia STD Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 353. Russia STD Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 354. Russia STD Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 355. Italy STD Testing Market Size, 2017-2032 (USD Million)
TABLE 356. Italy STD Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 357. Italy STD Testing Market Size, by Culture Tests, 2017-2032 (USD Million)
TABLE 358. Italy STD Testing Market Size, by Nucleic Acid Amplification Tests, 2017-2032 (USD Million)
TABLE 359. Italy STD Testing Market Size, by Rapid Tests, 2017-2032 (USD Million)
TABLE 360. Italy STD Testing Market Size, by Serology Tests, 2017-2032 (USD Million)
TABLE 361. Italy STD Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 362. Italy STD Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 363. Italy STD Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 364. Italy STD Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 365. Italy STD Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 366. Italy STD Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 367. Spain STD Testing Market Size, 2017-2032 (USD Million)
TABLE 368. Spain STD Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 369. Spain STD Testing Market Size, by Culture Tests, 2017-2032 (USD Million)
TABLE 370. Spain STD Testing Market Size, by Nucleic Acid Amplification Tests, 2017-2032 (USD Million)
TABLE 371. Spain STD Testing Market Size, by Rapid Tests, 2017-2032 (USD Million)
TABLE 372. Spain STD Testing Market Size, by Serology Tests, 2017-2032 (USD Million)
TABLE 373. Spain STD Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 374. Spain STD Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 375. Spain STD Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 376. Spain STD Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 377. Spain STD Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 378. Spain STD Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 379. China STD Testing Market Size, 2017-2032 (USD Million)
TABLE 380. China STD Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 381. China STD Testing Market Size, by Culture Tests, 2017-2032 (USD Million)
TABLE 382. China STD Testing Market Size, by Nucleic Acid Amplification Tests, 2017-2032 (USD Million)
TABLE 383. China STD Testing Market Size, by Rapid Tests, 2017-2032 (USD Million)
TABLE 384. China STD Testing Market Size, by Serology Tests, 2017-2032 (USD Million)
TABLE 385. China STD Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 386. China STD Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 387. China STD Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 388. China STD Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 389. China STD Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 390. China STD Testing Market Size, by End User, 2017-2032 (USD

Companies Mentioned

  • Abbott Laboratories
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biocartis Group NV
  • bioMérieux SA
  • Danaher Corporation
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche AG
  • Grifols, S.A.
  • Hologic, Inc.
  • MedMira Inc.
  • Meridian Bioscience, Inc.
  • OraSure Technologies, Inc.
  • Quidel Corporation
  • Sekisui Diagnostics, LLC
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech plc

Related Topics

Related Reports

Sexually Transmitted Disease Diagnostics Market - Global Forecast 2026-2032 - Product Image

Sexually Transmitted Disease Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Sexually Transmitted Diseases Diagnostics Market - Global Forecast 2025-2032 - Product Image

Sexually Transmitted Diseases Diagnostics Market - Global Forecast 2025-2032

  • Report
  • 188 Pages
  • Global
From
STD Diagnostics Market Report 2026 - Product Image

STD Diagnostics Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Sexually Transmitted Diseases (STD) Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Sexually Transmitted Diseases (STD) Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Sexually Transmitted Disease (STD) Testing Market - Forecast from 2026 to 2031 - Product Image

Sexually Transmitted Disease (STD) Testing Market - Forecast from 2026 to 2031

  • Report
  • 149 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.